alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1 

 

CERTIFICATION

 

I, Vincent C. Smith, certify that: 

 

1. I have reviewed this report on Form 10-Q of Quest Software, Inc.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly presentin all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a-15(e)) for the registrant and have: 

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, includingits consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and 

 

5. The registrant’s othercertifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing theequivalent functions): 

 

a) All significantdeficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: November 13, 2003
<PAGE>  1
                        ICHOR CORPORATION

           EXHIBIT 21 - SUBSIDIARIES OF THE REGISTRANT

<TABLE>
<CAPTION>
                                                                    Shareholding at
                                                                    December 31, 1996
Name of Subsidiary               Jurisdiction of Incorporation           (Direct)
------------------               -----------------------------      -----------------
<S>                              <C>                                <C>
ICHOR Services, Inc. (formerly
PDG Environmental Services, Inc.   State of Delaware                        100%

Ortek Inc. (formerly BC Ventures
Limited)                           State of Washington                      100%

501164 B.C. Ltd.                   Province of British Columbia, Canada     100%


</TABLE>
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the quarterly report of Appian,  Inc. (the "Company") on
Form  10-QSB  for the  period  ending  September  30,  2005,  as filed  with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Steven
R. Fey,  Principal  Accounting Officer of the Company,  certify,  pursuant to 18
U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the  Sarbanes-Oxley  Act of
2002, that, to the best of my knowledge and belief:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
     material respects,  the financial condition and result of operations of the
     Company.


/s/ STEVEN R. FEY
------------------------------
Steven R. Fey
Principal Accounting Officer
November 21, 2005

     A signed  original of this  written  statement  required by Section 906, or
     other document  authenticating,  acknowledging,  or otherwise  adopting the
     signature that appears in typed form within the electronic  version of this
     written  statement has been provided to the Company and will be retained by
     the Company and furnished to the Securities and Exchange  Commission or its
     staff upon  request.  The foregoing  certifications  are  accompanying  the
     Company's Form 10-QSB solely pursuant to section 906 of the  Sarbanes-Oxley
     Act of 2002  (subsections (a) and (b) of section 1350,  chapter 63 of title
     18,  United  States Code) and is not being filed as part of the Form 10-QSB
     or as a separate disclosure document.
<PAGE>
 
                                                                    Exhibit 23.1

                      CONSENT OF INDEPENDENT ACCOUNTANTS


We consent to the incorporation by reference in the registration statements of
PRI Automation, Inc. on Form S-8 (File Numbers 33-90702, 33-90726, 33-90732,
333-3408, 333-25217 and 333-41067) and Form S-3 (File Number 333-42167), of our
report dated November 12, 1997, on our audits of the consolidated financial
statements of PRI Automation, Inc. as of September 30, 1997 and 1996, and for
each of the three years in the period ended September 30, 1997, which report is
included in the Company's 1997 Annual Report on Form 10-K.



                                             /s/ Coopers & Lybrand L.L.P.

                                             COOPERS & LYBRAND L.L.P.

Boston, Massachusetts
December 29, 1997
**EXHIBIT 99.1**
**CERTIFICATION PURSUANT TO****18 U.S.C. SECTION 1350,****AS ADOPTED PURSUANT TO****SECTION 906 OF THE SARBANES-OXLEY ACT OF2002**
     In connection with the Annual Report ofConsolidated Water Co. Ltd. (the “Company”) on Form10-K/A for the fiscal year ended December 31, 2002 as filedwith the Securities and Exchange Commission on the date hereof(the “Report”), I, Jeffrey M. Parker, Chief ExecutiveOfficer of the Company, certify, pursuant to 18 U.S.C.§1350, as adopted pursuant to §906 of theSarbanes-Oxley Act of 2002, that:
     (1) The Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and
     (2) The information contained in the Reportfairly presents, in all material respects, the financialcondition and result of operations of the Company.
Date: June 26, 2003 By: /s/ Jeffrey M. Parker      Name: Jeffrey M. Parker     Title: Chief Executive Officer
**Exhibit 32.1**

 

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Inconnection with the Quarterly Report of SRS Labs, Inc. (the “Company”) on Form 10-Qfor the quarter ended March 31, 2008 as filed with the Securities andExchange Commission on the date hereof (the “Report”), Thomas C.K. Yuen, ChiefExecutive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,that, to his knowledge:

 

1.                                       The Report fully complies with therequirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

2.                                       The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

| Date: May 8, 2008 |   |                     |
|------------------------|--------|--------------------------|
|                   |   | By:                      | /s/  Thomas C.K. Yuen |
|                   |   | Thomas  C.K. Yuen        |
|                   |   | Chief  Executive Officer |

 

----
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 APR-01-1999
<PERIOD-END>                                   JUN-30-1999
<CASH>                                             3381263
<SECURITIES>                                             0
<RECEIVABLES>                                            0
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                   3496858
<PP&E>                                              882943
<DEPRECIATION>                                     (239728)
<TOTAL-ASSETS>                                     9314750
<CURRENT-LIABILITIES>                               146649
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                          18212463
<OTHER-SE>                                        (9044362)
<TOTAL-LIABILITY-AND-EQUITY>                       9314750
<SALES>                                                  0
<TOTAL-REVENUES>                                         0
<CGS>                                                    0
<TOTAL-COSTS>                                            0
<OTHER-EXPENSES>                                    570509
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                    1966
<INCOME-PRETAX>                                    (528870)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                                (528870)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       (528870)
<EPS-BASIC>                                         (.03)
<EPS-DILUTED>                                            0 <F1>

<FN>
<F1>
Fully diluted EPS not computed on loss.
</FN>

</TABLE>
#### Irma S. OCHOA, Petitioner, v. OFFICE OF PERSONNEL MANAGEMENT, Respondent.

No. 2011-3069.

United States Court of Appeals, Federal Circuit.

July 12, 2011.

Edward P. Fahey Jr., Laredo, TX, for Petitioner.

Before GAJARSA, MAYER, and PROST, Circuit Judges.

ON MOTION

ORDER

PER CURIAM.

The Office of Personnel Management (OPM) moves to dismiss Irma S. Ochoa’s petition for review as untimely.

On October 22, 2010, an administrative judge issued an initial decision, affirming *977OPM’s denial of Ochoa’s claims, and notifying Ochoa that, absent an appeal to the Board, the decision would become final on November 26, 2010. The Board further informed Ochoa that any petition for review must be received by this court within 60 calendar days of the date the initial decision became final. Ochoa did not appeal the initial decision to the Board. Ochoa’s petition for review was received by the court on January 27, 2011, 62 days after the Board’s decision became final on November 26.

A petition for review must be received by the court within 60 days of receipt of notice of the Board’s final order. 5 U.S.C. § 7703(b)(1). To be timely filed, the petition must be received by this court on or before the date that the petition is due. *Pinat v. Office of Personnel Management,*931 F.2d 1544, 1546 (Fed.Cir.1991) (petition is filed when received by this court; court dismissed petition received nine days late).

Because Ochoa’s petition was not timely received by this court, it must be dismissed based on controlling precedent of this court. *See Oja v. Dep’t of the Army,*405 F.3d 1349, 1360 (Fed.Cir.2005) (“Seeing no specific authorization for the equitable tolling of section 7703(b)(1), we find that the congressionally approved statements of Rules 15(a)(1) and 26(b)(2) require the conclusion first reached in *Mon-zo*and herein followed. Compliance with the filing deadline for 5 U.S.C. § 7703(b)(1) is a prerequisite to our exercise of jurisdiction over this case.”).

Accordingly,

It Is Ordered That:

(1) OPM’s motion to dismiss is granted.

(2) Each side shall bear its own costs.
Exhibit 32.2

                        CERTIFICATION OF PERIODIC REPORT
                      As adopted pursuant to Section 906 of
                         the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q for the third quarter ended
March 31, 2007 of Integrated BioPharma, Inc. (the "Company") as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), Dina L.
Masi, the Senior Vice President and Chief Financial Officer of Integrated
BioPharma, Inc. certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, 18 U.S.C. Section 1350, that to his knowledge:

(1)      the Report fully complies with the  requirements  of Section 13(a)
         or 15(d) of the Securities  Exchange Act of 1934 (15 U.S.C.
         78m or 78o(d)); and

(2)      the information  contained in the Report fairly presents,  in all
         material  respects,  the financial  condition and results of
         operations of the Company.

This certification accompanies the Report pursuant to Section 906 of
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.


Date: May 9, 2007      By: /s/ Dina L. Masi
                        --------------------
                        Name: Dina L. Masi
                        Title: Senior Vice President & Chief Financial Officer
Exhibit 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Altair Nanotechnologies Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Fallini, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.










/s/  John FalliniJohn Fallini, Chief Financial Officer

November 5, 2010
EXHIBIT 32.1
                               ------------

                               CERTIFICATION
                      PURSUANT TO 18 U.S.C. SECTION 1350

   AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Annual Report on Form 10-K (the
"Report") of AMCON Distributing Company (the "Company") for the fiscal year
ended September 30, 2006, I, Christopher H. Atayan, Chief Executive Officer
and Principal Executive Officer of the Company, hereby certify pursuant to 18
U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to my knowledge, that:

    (1)the Report fully complies with the requirements of Section 13(a) or
       15(d) of the Securities Exchange Act of 1934; and

    (2)the information contained in the Report fairly presents, in all
       material respects, the financial condition and results of operations
       of the Company.


Date: December 28, 2006         /s/ Christopher H. Atayan
                             ------------------------------
                             Title: Chief Executive Officer
                             and Vice Chairman



A signed original of this written statement required by Section 906 has been
provided to AMCON Distributing Company and will be retained by AMCON
Distributing Company and furnished to the Securities and Exchange Commission
or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS FOUND ON PAGES 1 - 3 OF THE COMPANY'S FORM
10-Q FOR THE QUARTER ENDED MARCH 31, 1998 AND IS QUALIFIED BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                         476,165
<SECURITIES>                                         0
<RECEIVABLES>                                   45,197
<ALLOWANCES>                                         0
<INVENTORY>                                 12,001,639
<CURRENT-ASSETS>                             3,703,206
<PP&E>                                       6,158,379
<DEPRECIATION>                               2,703,106
<TOTAL-ASSETS>                              20,016,485
<CURRENT-LIABILITIES>                        8,322,971
<BONDS>                                      5,750,323
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        24,336
<OTHER-SE>                                   5,918,855
<TOTAL-LIABILITY-AND-EQUITY>                20,016,485
<SALES>                                      7,914,669
<TOTAL-REVENUES>                             7,914,669
<CGS>                                        3,175,893
<TOTAL-COSTS>                                8,257,667
<OTHER-EXPENSES>                                  (80)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             187,099
<INCOME-PRETAX>                              (530,017)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (530,017)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                              1,133,365
<CHANGES>                                            0
<NET-INCOME>                                   603,348
<EPS-PRIMARY>                                     0.25
<EPS-DILUTED>                                     0.25
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HIV Vaccine Research and Design (HIVRAD) Program (P01).                    

*Date:*                         November 6-7, 2017.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Audrey O. Lau, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC-9823, Rockville, MD 20852, 240-669-2081.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: October 4, 2017.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-21830 Filed 10-10-17; 8:45 am]

 BILLING CODE 4140-01-P
**Exhibit 99.2**

 

**STATEMENT OF CHIEF FINANCIAL OFFICER PURSUANT TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report of SRS Labs, Inc. (the “Company”) on Form 10-Q forthe quarter ended March 31, 2003 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), Janet M. Biski, Chief FinancialOfficer of the Company, certifies to the best of her knowledge, pursuant to 18U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002,that:

 

1.                                       The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of1934; and

 

2.                                       The information contained in the Reportfairly presents, in all material respects, the financial condition and resultof operations of the Company.

 
|               |   |                                                    |
|--------------------|--------|---------------------------------------------------------|
| Date: May 15, 2003 | By:    | /s/  JANET M. BISKI                                     |
|               |   | Janet  M. Biski                                         |
|               |   | Chief  Financial Officer  (Principal Financial Officer) |

 

A signed original of thiswritten statement required by Section 906 has been provided to SRS Labs, Inc.and will be retained by SRS Labs, Inc. and furnished to the Securities andExchange Commission or its staff upon request.

 

----
#### In re Bertrand MARC.

No. 2010-1540.

United States Court of Appeals, Federal Circuit.

May 12, 2011.

Jeffrey M. Goehring, Young & Thompson, of Alexandria, VA, argued for the appellant. With him on the brief was Andrew J. Patch.

Joseph G. Piccolo, Associate Solicitor, Office of the Solicitors, United States Patent and Trademark Office, of Alexandria, VA, argued for appellee. With him on the brief were Raymond T. Chen, Solicitor, and Brian T. Racilla, Associate Solicitor.

*956LINN, CLEVENGER, and MOORE, Cii’cuit Judges.

JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. *See*Fed. Cir. R. 36.